Business & FinanceHybrid
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Gilead SciencesEl Segundo, CA
$205,615–266,090/yr (other US); $226,185–292,710/yr (Bay Area)
Posted Oct 13, 2026
What you’d do
Lead global market access strategy for Kite's autoimmune cell therapy portfolio, supporting early and late-stage development programs and launch preparation. Hybrid role with 3 days onsite in El Segundo, Thousand Oaks, or Foster City, CA. Found on the employer's careers page on Oct 18, 2026. Apply through the link.
You’ll need
- 3+ years supporting autoimmune disease programs
- Experience in market access, medical affairs, or commercial strategy
- Understanding of autoimmune treatment paradigms
- Hybrid onsite 3 days/week in California
Our summary of the listing. The full listing has the details.